Location: San Francisco, CA
CIK: 0001776382 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value: $351M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | 9,699,925 | $78.47M | 22.3% | $8.09 * | $39.31 | -72.3% | COM | 00166B105 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 1,448,720 | $70.65M | 20.1% | $48.77 * | $36.46 | +23.5% | COM | 413197104 |
| VTYX | VENTYX BIOSCIENCES INC | 5,011,536 | $61.29M | 17.5% | $12.23 * | $18.95 | -21.1% | COM | 92332V107 |
| PHVS | PHARVARIS N V | 2,301,451 | $50.86M | 14.5% | $22.10 * | $31.46 | -40.8% | COM | N69605108 |
| — | CINCOR PHARMA INC | 2,145,035 | $40.41M | 11.5% | $18.84 | $17.64 | — | COM | 17240Y109 |
| — | IMPEL PHARMACEUTICALS INC | 2,759,791 | $25.72M | 7.3% | $9.32 | $8.85 | — | COM | 45258K109 |
| — | AKERO THERAPEUTICS INC | 2,171,664 | $20.52M | 5.8% | $9.45 | $19.15 | — | COM | 00973Y108 |
| — | ELEVATION ONCOLOGY INC | 1,866,339 | $2.613M | 0.7% | $1.40 | $13.57 | — | COM | 28623U101 |
| — | VERONA PHARMA PLC | 161,897 | $678K | 0.2% | $4.19 | $9.65 | — | SPONSORED ADS | 925050106 |